KKR, Novo Nordisk, others bid for Healthium buy

Global private equity major KKR and pharma major Novo Nordisk have submitted final bids to acquire…

Biocon leads India’s push into weight-loss drugs as patents set to expire

Biocon Ltd is leading India’s push into weight loss drugs as patents for some of the…

Novo’s $1,000 diabetes drug can be made for less than $5 a month: Study

Diabetes drug Ozempic, priced at ₹$1,000, could be manufactured for less than $5 a month, a…

Germany mulls export ban on Novo Nordisk’s Ozempic amid global shortage of weight-loss drugs: report

Germany is mulling a ban on export of Novo Nordisk A/S’s diabetes drug Ozempic amid a…

How weight-loss drugs trounced a luxury giant, explained

What’s common between Denmark’s GDP growth and humanity’s expanding waistlines? The answer is, a pharma company.…

Novo Nordisk launches weight loss injection Wegovy in UK

Danish drugmaker Novo Nordisk has launched its weight-loss injection Wegovy in Britain in a bid to…

Weight-loss drug Wegovy cuts risks of heart attack, stroke by 20%: Study

The shares of Novo Nordisk A/S witnessed the biggest intraday jump in two decades after a…

WHO calls for ending insulin monopoly

Mumbai The World Health Organization (WHO) will launch a program to make available generic versions of…

Novo Nordisk may raise sales target of obesity drug after stellar demand – Times of India

New Delhi: novo nordisk A/S is looking to increase sales guidance for its obesity drug, following…